temozolomide,irinotecan
eli lilly
['temozolomide', 'irinotecan', 'solid tumor', 'loxo']
at #asco23, we are presenting data on the recommended phase 2 dose for a cdk 4/6 inhibitor in combination w/ irinotecan and temozolomide in pediatric patients w/ relapsed/refractory solid tumors. see the details here: #clinicaltrials #pediatrictumors 
Dedicated to communicating the latest science & innovation from Loxo@Lilly. Tweets intended for US oncology HCPs. See our community guidelines: https://t.co/1q8vAe63mK